natgillin/translations-raw huggingface dataset:
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 5 boxes with bottles of 200 mL solution for infusion)
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje 5 škatel s steklenico z 200 ml raztopine za infundiranje)
Headache Dizziness Sleep disorders Taste disorders
− glavobol, omotica, motnje spanja ali motnje okusa
Probenecid interferes with renal secretion of ciprofloxacin.
Probenecid ovira izločanje ciprofloksacina skozi ledvice.
CIPROXIN 750 mg film-coated tablets oral use
CIPROXIN 750 mg filmsko obložene tablete peroralna uporaba
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION [To be completed nationally.]
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET {MM/LLLL} [Izpolni država članica]
Geriatric patients should receive a dose selected according to the severity of the infection and the patient's creatinine clearance.
Starejšim bolnikom se daje glede na resnost bolezni in očistek kreatinina najmanjši možni odmerek zdravila.
What Ciprofloxacin Bayer looks like and contents of the pack Solution for infusion [To be completed nationally]
Izgled zdravila Ciprofloksacin Bayer in vsebina pakiranja raztopina za infundiranje [Izpolni država članica]
CIPROBAY 500 mg film-coated tablets oral use
CIPROBAY 500 mg filmsko obložene tablete peroralna uporaba
CIPROBAY 250 mg film-coated tablets oral use
CIPROBAY 250 mg filmsko obložene tablete peroralna uporaba
Marketing Authorisation Holder and Manufacturer [See Annex I - To be completed nationally]
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET [Glejte Dodatek I - Izpolni država članica]
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 1 bottle of 200 mg / 100 mL solution for infusion)
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje 1 steklenico z 200 mg/100 ml raztopine za infundiranje)
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing wraps with bags of 200 mL solution for infusion)
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje omote z vrečami z 200 ml raztopine za infundiranje)
Inhalation anthrax post-exposure prophylaxis and curative treatment for persons able to receive treatment by oral route when clinically appropriate.
inhalacijski vranični prisad (zaščita in zdravljenje po izpostavitvi povzročitelju) pri osebah, ki se lahko zdravijo peroralno, če je to klinično primerno; zdravljenje je treba začeti takoj po domnevni ali potrjeni izpostavitvi povzročitelju.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing wraps with bags of 100 mL solution for infusion)
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje omote z vrečami s 100 ml raztopine za infundiranje)
PHARMACEUTICAL FORM Granules and solvent for oral suspension [To be completed nationally]
FARMACEVTSKA OBLIKA zrnca in vehikel za peroralno suspenzijo [Izpolni država članica]
SPC Section 4.2 Posology and method of administration
Povzetek glavnih značilnosti zdravila, poglavje 4.2: Odmerjanje in način uporabe
Monitoring of ropinirole-related side effects and dose adjustment as appropriate is recommended during and shortly after co-administration with ciprofloxacin (see section
Priporoča se klinično spremljanje bolnika glede neželenih učinkov in ustrezna prilagoditev odmerkov ropinirola med zdravljenjem s ciprofloksacinom in po koncu zdravljenja s ciprofloksacinom (glejte poglavje 4.4).
Empty the bottle containing the granules for oral suspension into the opening of the bottle of solvent.
Stresite zrnca za peroralno suspenzijo iz stekleničke v plastenko, ki vsebuje vehikel.
Toxic epidermal necrolysis (potentially lifethreatening)
StevensJohnsonov sindrom (lahko smrtno nevaren) toksična epidermalna nekroliza (lahko smrtno nevarna)
Photosensitivity reactions (see section 4.4)
kože in podkožja srbenje koprivnica reakcije (glejte poglavje 4.4)
Unless compatibility with other infusion solutions/drugs has been confirmed, the infusion solution must always be administered separately.
Raztopino za infundiranje je treba vedno dati ločeno, razen če je bilo dokazano, da je kompatibilna z drugimi raztopinami za infundiranje/zdravili.
- muscle pain, inflammation of the joints, increased muscle tone, cramping, tendon ruptureespecially of the large tendon at the back of the ankle (Achilles tendon) (see Section 2: Take special care with Ciprofloxacin Bayer) - blood or crystals in the urine (see Section 2: Take special care with Ciprofloxacin Bayer), urinary tract inflammation - excessive sweating - abnormal levels of a clotting factor (prothromibin) increased levels of the enzyme amylase
− mišične bolečine, vnetje sklepov, povečan tonus mišic, krči, raztrganje tetiv - posebno dolge tetive na zadnji strani gležnja (Ahilova tetiva) (glejte poglavje 2: Bodite posebno pozorni pri uporabi zdravila Ciprofloksacin Bayer)
Malignant external otitis
maligno vnetje zunanjega ušesa
CIPROXIN 250 mg film-coated tablets oral use
CIPROXIN 250 mg filmsko obložene tablete peroralna uporaba
• infections of the testicles
• okužbe sečil
Glucose Load
Vsebnost glukoze
10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose, corresponding to a 0.1 mL/kg body weight twice daily to 0.2 mL/kg body weight twice daily with a maximum of 7.5 mL per dose
10 mg/kg do 20 mg/kg telesne mase dvakrat na dan; največ 750 mg na odmerek kar odgovarja 0,1 ml/kg telesne mase dvakrat na dan do 0,2 ml/kg telesne mase dvakrat na dan; največ 7,5 ml na odmerek
What Ciprofloxacin Bayer looks like and contents of the pack Oral suspension (in single dose sachets) [To be completed nationally]
Izgled zdravila Ciprofloksacin Bayer in vsebina pakiranja peroralna suspenzija, vrečice za enkratno uporabo [Izpolni država članica]
• complicated urinary tract infections, including infections that have reached the kidneys
− zapletene okužbe sečil, vključno z okužbami ledvic (pielonefritis)
250 mg/5 ml oral suspension oral use
250 mg/5 ml peroralna suspenzija peroralna uporaba
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose.
10 mg/kg do 15 mg/kg telesne mase dvakrat na dan; največ 500 mg na odmerek
BEFORE YOU TAKE CIPROFLOXACIN BAYER
Preden vzamete zdravilo Ciprofloksacin Bayer
• lung and bronchial infections in children and adolescents suffering from cystic fibrosis
− pljučno in bronhialno poslabšanje cistične fibroze pri otrocih in mladostnikih − zapletene okužbe sečil, vključno z okužbami ledvic (pielonefritis)
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose, corresponding to a 0.1 mL/kg body weight twice daily to 0.15 mL/kg body weight twice daily with a maximum of 5 mL per dose
10 mg/kg do 15 mg/kg telesne mase dvakrat na dan; največ 500 mg na odmerek kar odgovarja 0,1 ml/kg telesne mase dvakrat na dan do 0,15 ml/kg telesne mase dvakrat na dan; največ 5 ml na odmerek
500 mg/5 ml oral suspension oral use use
500 mg/5 ml peroralna suspenzija peroralna uporaba
5 mL twice daily to 7.5 mL twice daily (one 5-mL measuring spoonful twice daily up to one and a half 5mL measuring spoonfuls twice daily)
5 - 7,5 ml dvakrat na dan (ena do ena in pol 5-ml merilna žlička dvakrat na dan)
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose, corresponding to a 0.2 mL/kg body weight twice daily to 0.3 mL/kg body weight twice daily with a maximum of 10 mL per dose
10 mg/kg do 15 mg/kg telesne mase dvakrat na dan; največ 500 mg na odmerek kar odgovarja 0,2 ml/kg telesne mase dvakrat na dan do 0,3 ml/kg telesne mase dvakrat na dan; največ 10 ml na odmerek
50 mg/ml oral suspension oral use
50 mg/ml peroralna suspenzija peroralna uporaba
10 mL twice daily (two 5-mL measuring spoonfuls twice daily)
10 ml dvakrat na dan (dve 5-ml merilni žlički dvakrat na dan)
Haemolytic anaemia Agranulocytosis Pancytopenia (lifethreatening) Bone marrow depression (lifethreatening)
Bolezni krvi in limfatičnega sistema eozinofilija levkopenija anemija nevtropenija levkocitoza trombocitopenija trombocitemija hemolitična anemija agranulocitoza pancitopenija (smrtno nevarna) depresija kostnega mozga (smrtno
Ciprobay XR 1000 mg modified release tablets oral use
Ciprobay XR 1000 mg tablete s prirejenim sproščanjem peroralna uporaba
10 mL twice daily to 15 mL twice daily (two 5-mL measuring spoonfuls twice daily up to three 5-mL measuring spoonfuls twice daily)
10 - 15 ml dvakrat na dan (dve do tri 5-ml merilne žličke dvakrat na dan)
Rare side effects (between 1 and 10 in every 10,000 people are likely to get these):
Redki (manj kot 1 od 1.000, ampak več kot 1 od 10.000 bolnikov)
Ciprobay XR 500 mg modified release tablets oral use
Ciprobay XR 500 mg tablete s prirejenim sproščanjem peroralna uporaba
CIPROXIN 500 mg film-coated tablets oral use
CIPROXIN 500 mg filmsko obložene tablete peroralna uporaba
100 mg film-coated tablets oral use
100 mg filmsko obložene tablete peroralna uporaba
250 mg film-coated tablets oral use
250 mg filmsko obložene tablete peroralna uporaba
750 mg film-coated tablets oral use
750 mg filmsko obložene tablete peroralna uporaba
CIPROBAY 200 mg/100 ml solution for infusion intravenous use
CIPROBAY 200 mg/100 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
2.5 mL twice daily to 5 mL twice daily (half 5-mL measuring spoonful twice daily up to one 5-mL measuring spoonful twice daily)
2,5 - 5 ml dvakrat na dan (pol do ena 5-ml merilna žlička dvakrat na dan)
Ciprofloxacin Bayer), urinary tract inflammation - fluid retention or excessive sweating - abnormal levels of a clotting factor (prothrombin) or increased levels of the enzyme amylase
− nenormalne vrednosti faktorja strjevanja krvi (protrombin) ali zvečane vrednosti encima amilaza
CIPROXIN 100 mg/50 ml solution for infusion intravenous use
CIPROXIN 100 mg/50 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
oral use
Način uporabe
15 mL twice daily (three 5-mL measuring spoonfuls twice daily)
15 ml dvakrat na dan (tri 5-ml merilne žličke dvakrat na dan)
Ask your doctor or pharmacist if you are not sure how to take Ciprofloxacin Bayer.
Ne vozite ter ne upravljajte s stroji, dokler ne veste, kako se vaše telo odziva na zdravilo Ciprofloksacin Bayer.
CIPROBAY 100 mg/50 ml solution for infusion intravenous use
CIPROBAY 100 mg/50 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
- inflammation of the bowel (colitis) linked to antibiotic use (can be fatal in very rare cases) (see
Infekcijske in parazitske bolezni glivične okužbe kolitis, ki nastane zaradi jemanja antibiotikov (zelo redko z možnim smrtnim izidom) (glejte poglavje
CIPROXIN XR 500 mg modified release tablets oral use
CIPROXIN XR 500 mg tablete s prirejenim sproščanjem peroralna uporaba
A 60-minute intravenous infusion of 200 mg ciprofloxacin or the oral administration of 250 mg ciprofloxacin, both given every 12 hours, produced an equivalent area under the serum concentration time curve (AUC).
Pri 60-minutnem intravenskem infundiranju 200 mg ciprofloksacina ali po peroralni uporabi 250 mg ciprofloksacina na 12 ur je AUC enaka.
Remember to drink plenty of fluids while you are taking Ciprofloxacin Bayer.
Med zdravljenjem z zdravilom Ciprofloksacin Bayer pijte zadostne količine tekočin.
Frequency not known (cannot be estimated from the available data) - troubles associated with the nervous system such as pain, burning, tingling, numbness and/ or weakness in extremities - severe cardiac rhythm abnormalities, irregular heart beat (Torsades de Pointes)
− težave v povezavi z živčnim sistemom (npr. bolečina, žarenje, ščemenje, odrevenelost in/ali oslabelost okončin)
CIPROXIN 200 mg/100 ml solution for infusion intravenous use
CIPROXIN 200 mg/100 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
Ciprofloxacin Bayer and associated names (see Annex I) 250 mg oral suspension in single-dose sachets [See Annex I - To be completed nationally]
Ciprofloksacin Bayer in povezana imena (Glejte Dodatek I) 250 mg peroralna suspenzija, vrečice za enkratno uporabo [Glejte Dodatek I - Izpolni država članica]
CIPROXIN XR 1000 mg modified release tablets oral use
CIPROXIN XR 1000 mg tablete s prirejenim sproščanjem peroralna uporaba
CIPROBAY 400 mg/200 ml solution for infusion intravenous use
CIPROBAY 400 mg/200 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
HOW TO USE CIPROFLOXACIN BAYER
KAKO UPORABLJATI ZDRAVILO CIPROFLOKSACIN BAYER
Respiratory, Thoracic and Mediastinal Disorders
Okvarjeno delovanje ledvic in jeter
It is recommended that the INR should be monitored frequently during and shortly after co-administration of ciprofloxacin with an oral anticoagulant agent.
Med zdravljenjem in kmalu po sočasni uporabi ciprofloksacina in peroralnega antikoagulanta je treba pogosteje določati vrednosti INR.
Taking the Ready-to-Use Suspension
Jemanje peroralne suspenzije
400 mg/200 ml solution for infusion intravenous use
400 mg/200 ml raztopina za infundiranje intravenska uporaba 2 mg / ml
500 mg film-coated tablets oral use
500 mg filmsko obložene tablete peroralna uporaba
5-mL twice daily to 10 mL twice daily (one 5-mL measuring spoonful twice daily up to two 5-mL measuring spoonfuls twice daily)
5 - 10 ml dvakrat na dan (ena do dve 5-ml merilni žlički dvakrat na dan)
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 400 mg per dose.
10 mg/kg telesne mase dvakrat na dan do 15 mg/kg telesne mase dvakrat na dan; največ 400 mg na odmerek
Microorganisms
Organskisistem
HOW TO TAKE CIPROFLOXACIN BAYER
KAKO JEMATI ZDRAVILO CIPROFLOKSACIN BAYER
CIPROXIN 400 mg/200 ml solution for infusion intravenous use
CIPROXIN 400 mg/200 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 5 or 40 boxes with bottles of 100 mL solution for infusion)
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje 5 škatel s steklenico s 100 ml raztopine za infundiranje)
• sucralfate
− sukralfat
Excretion of ciprofloxacin (% of dose) Intravenous Administration Urine
izločanje ciprofloksacina (% odmerka) intravenska uporaba seč blato ciprofloksacin presnovki (M1 - M4)
100 mg/50 ml solution for infusion intravenous use
100 mg/50 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
Ciprofloxacin Bayer and associated names (see Annex I) 750 mg film-coated tablets [See Annex I - To be completed nationally]
Ciprofloksacin Bayer in povezana imena (Glejte Dodatek I) 750 mg filmsko obložene tablete [Glejte Dodatek I - Izpolni država članica]
CIPROXIN 1000 mg modified release tablets oral use
CIPROXIN 1000 mg tablete s prirejenim sproščanjem peroralna uporaba
10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose, corresponding to a 0.2 mL/kg body weight twice daily to 0.4 mL/kg body weight twice daily with a maximum of 15-mL per dose
10 mg/kg do 20 mg/kg telesne mase dvakrat na dan; največ 750 mg na odmerek kar odgovarja 0,2 ml/kg telesne mase dvakrat na dan do 0,4 ml/kg telesne mase dvakrat na dan;
Mycotic superinfections
− glivične okužbe
Bayer HealthCare AG D-513 68 Leverkusen Germany
Bayer HealthCare AG D-513 68 Leverkusen Nemčija
- inflammation of the bowel (colitis) linked to antibiotic use (can be fatal in very rare cases) (see Section 2: Take special care with Ciprofloxacin Bayer) - changes to the blood count (leukopenia, leukocytosis, neutropenia, anaemia), increased or decreased amounts of a blood clotting factor (thrombocytes)
− črevesno vnetje (kolitis) povezano z uporabo antibiotikov (smrtno nevarno v redkih primerih) (glejte poglavje 2: Bodite posebno pozorni pri uporabi zdravila Ciprofloksacin Bayer)
Lactation
− oglušitev
Muscular weakness Tendinitis Tendon rupture (predominantly Achilles tendon) (see section 4.4) Exacerbation of symptoms of myasthenia gravis (see section 4.4)
spanja motnje okusa tremor krči (glejte poglavje 4.4) vrtoglavica motnje ravnotežja motnje vohanja zvišan intrakranialni tlak poglavje 4.4)
• Inhalation anthrax (post-exposure prophylaxis and curative treatment) Children and adolescents
• vdihavanje antraksa (profilaksa po izpostavitvi in zdravljenje),
Ciprofloxacin Bayer and associated names (see Annex I) 400 mg/200 mL solution for infusion [See Annex I - To be completed nationally]
Ciprofloksacin Bayer in povezana imena (Glejte Dodatek I) 400 mg/200 ml raztopina za infundiranje [Glejte Dodatek I - Izpolni država članica]
Ciprofloxacin Bayer and associated names (see Annex I) 500 mg oral suspension in single-dose sachets [See Annex I - To be completed nationally]
Ciprofloksacin Bayer in povezana imena (Glejte Dodatek I) 500 mg peroralna suspenzija, vrečice za enkratno uporabo [Glejte Dodatek I - Izpolni država članica]
Ciprofloxacin Bayer and associated names (see Annex I) 100 mg / 50 mL solution for infusion [See Annex I - To be completed nationally]
Ciprofloksacin Bayer in povezana imena (Glejte Dodatek I) 100 mg/50 ml raztopina za infundiranje [Glejte Dodatek I - Izpolni država članica]
Ciprofloxacin Bayer and associated names (see Annex I) 250 mg film-coated tablets [See Annex I - To be completed nationally]
Ciprofloksacin Bayer in povezana imena (Glejte Dodatek I) 250 mg filmsko obložene tablete [Glejte Dodatek I - Izpolni država članica]
Infections of the gastro-intestinal tract and intraabdominal infections
5 dni okužbe prebavil in intraabdominalne okužbe driska, ki jo povzroča Vibrio cholerae
7 to 14 days
7 do 14 dni okužbe kosti in sklepov
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER WRAP (containing 1 infusion bag of 400 mg / 200 mL solution for infusion)
PODATKI NA ZUNANJI OVOJNINI ZUNANJI OMOT (vsebuje 1 vrečo z 200 ml raztopine za infundiranje)
5 mL twice daily (one 5-mL measuring spoonful twice daily)
5 ml dvakrat na dan (ena 5-ml merilna žlička dvakrat na dan)
Ciprofloxacin Bayer and associated names (see Annex I) 200 mg / 100 mL solution for infusion [See Annex I - To be completed nationally]
Ciprofloksacin Bayer in povezana imena (Glejte Dodatek I) 200 mg/100 ml raztopina za infundiranje [Glejte Dodatek I - Izpolni država članica]
250 mg oral suspension (in single dose sachets)
250 mg peroralna suspenzija, vrečice za enkratno uporabo peroralna uporaba
3 days
3 dni nezapleten cistitis
Nausea Diarrhoea
Okužbe spolovil
Renal impairment
− slabo delovanje ledvic
Infections of the upper respiratory tract
Inhalacijski vranični prisad
Aerobic Gram-negative micro-organisms
*(2) aerobni, po Gramu negativni mikroorganizmi
(pyelonephritis)
(holestatski ikterus)
Section 2: Take special care with Ciprofloxacin Bayer) - increased blood sugar (hyperglycemia) - anxiety reaction, strange dreams, depression, mental disturbances (psychotic reactions) (see
Psihiatrične motnje psihomotorič na hiperaktivnos t/ agitacija zmedenost in dezorientiranost anksiozna reakcija nočne more depresija halucinacije psihotične reakcije (glejte poglavje 4.4)
Section 2: Take special care with Ciprofloxacin Bayer) - changes to the blood count (leukopenia, leukocytosis, neutropenia, anaemia), increased or decreased amounts of a blood clotting factor (thrombocytes) - allergic reaction, swelling (oedema), or rapid swelling of the skin and mucous membranes
− spremembe v krvni sliki (levkopenija, levkocitoza, nevtropenija, anemija), zvečane ali zmanjšane vrednosti krvnih ploščic (trombocitov) (glejte poglavje 2: Bodite posebno pozorni pri jemanju zdravila Ciprofloksacin Bayer)
Increase in transaminases Increased bilirubin
zvišanje vrednosti bilirubina nevarno jetrno odpoved)
Bayer Healthcare AG 51368 Leverkusen, Germany
Bayer HealthCare AG 51368 Leverkusen, Nemčija
Bayer HealthCare AG 51368 Leverkusen, Germany
Bayer Healthcare AG 51368 Leverkusen, Nemčija
Take the tablets exactly as your doctor has told you.
Natančno upoštevajte zdravnikova navodila.
Bayer Healthcare AG D-51368 Leverkusen, Germany
Bayer HealthCare AG D-51368 Leverkusen, Nemčija
Bayer HealthCare AG D-51368 Leverkusen, Germany
Bayer Healthcare AG D-51368 Leverkusen, Nemčija
Common side effects (between 1 and 10 in every 100 people are likely to get these):
Pogosti (manj kot 1 od 10, ampak več kot 1 od 100 bolnikov)
If you stop your course of Ciprofloxacin Bayer
Če ste prenehali uporabljati zdravilo Ciprofloksacin Bayer
- fungal superinfections - a high concentration of eosinophils, a type of white blood cell - loss of appetite (anorexia) - hyperactivity or agitation - headache, dizziness, sleeping problems, or taste disorders - vomiting, abdominal pain, digestive problems such as stomach upset (indigestion/heartburn), or wind - increased amounts of certain substances in the blood (transaminases and/or bilirubin) - rash, itching, or hives - joint pain in adults - poor kidney function - pains in your muscles and bones, feeling unwell (asthenia), or fever - increase in blood alkaline phosphatase (a certain substance in the blood)
- okužbe dihal - dolgotrajne ali ponavljajoče se okužbe ušes in obnosnih sinusov - okužbe sečil - okužbe mod (testisov) - okužbe spolnih organov pri ženskah - okužbe prebavil in okužbe v trebušni votlini - okužbe kože in mehkih tkiv - okužbe kosti in sklepov - zdravljenje okužb pri bolnikih z zmanjšanim številom belih krvnih celic (nevtropenija) - preprečevanje okužb pri bolnikih z zmanjšanim številom belih krvnih celic (nevtropenija) - vranični prisad (izpostavljenost povzročitelju z vdihavanjem)
Bayer HealthCare AG D-51368 Leverkusen Germany
Bayer HealthCare AG D-51368 Leverkusen Nemčija
NAME OF THE MEDICINAL PRODUCT Ciprofloxacin Bayer and associated names (see Annex I) 750 mg film-coated tablets [See Annex I - To be completed nationally] Ciprofloxacin
Ciprofloksacin Bayer in povezana imena (Glejte Dodatek I) 750 mg filmsko obložene tablete [Glejte Dodatek I - Izpolni država članica] ciprofloksacin
• You may experience psychiatric reactions the first time you take Ciprofloxacin Bayer.
− Po prvi uporabi zdravila Ciprofloksacin Bayer se lahko pojavijo psihiatrične reakcije.
- small, pin-point bleeding under the skin (petechiae); various skin eruptions or rashes (for example, the potentially fatal Stevens-Johnson syndrome or toxic epidermal necrolysis) - muscle weakness, tendon inflammation, tendon rupture - especially of the large tendon at the back of the ankle (Achilles tendon) (see Section 2: Take special care with Ciprofloxacin Bayer); worsening of the symptoms of myasthenia gravis (see Section 2: Take special care with Ciprofloxacin Bayer)
mišičnoskeletnega sistema in vezivnega tkiva skeletne bolečine (npr. bolečine v okončinah, hrbtu, prsnem košu) artralgija artritis zvečanje mišičnega tonusa in krči oslabelost tendinitis raztrganine tetiv (predvsem Ahilove tetive) (glejte poglavje poslabšanje miastenije gravis (glejte poglavje
Important information about some of the ingredients of Ciprofloxacin Bayer As Ciprofloxacin Bayer contains 1.4 g sucrose per 5-mL measuring spoonful, this has to be taken into consideration in terms of daily intake.
Pomembne informacije o nekaterih sestavinah zdravila Zdravilo Ciprofloksacin Bayer vsebuje 1,4 g saharoze na 5 ml merilno žličko.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SINGLE DOSE SACHETS 250 MG
VREČICA ZA ENKRATNO UPORABO 250 MG
Important information about some of the ingredients of Ciprofloxacin Bayer Sodium [To be completed nationally]
Pomembne informacije o nekaterih sestavinah zdravila Ciprofloksacin Bayer Natrij [Izpolni država članica]
Consequently, caution is advised when treating patients with these infections.
Klinične izkušnje pri drugih hudih okužbah so omejene, zato je pri bolnikih s temi okužbami potrebna posebna pozornost.
However, do not take Ciprofloxacin Bayer tablets with dairy products such as milk or yoghurt or with fortified fruit-juices (e.g. calcium-fortified orange juice).
Ne jemljite tablet hkrati z mlečnimi izdelki (npr. mleko, jogurt) ali s pijačami, obogatenimi z minerali (npr. s kalcijem obogaten pomarančni sok).
Ciprofloxacin Bayer and associated names (see Annex I) 500 mg film-coated tablets [See Annex I - To be completed nationally]
Ciprofloksacin Bayer in povezana imena (Glejte Dodatek I) 500 mg filmsko obložene tablete [Glejte Dodatek I - Izpolni država članica]